Explore the frontier of life sciences and healthcare innovation. From breakthrough therapeutics and longevity research to the deep tech investments shaping tomorrow's treatments, discover the trends and breakthroughs redefining global health.
The $44 billion longevity market measures everything except whether extended lives feel worth living. A new concept called Joyspan is changing that — and capital is starting to follow.
Memento Medicines closed a $93M Series A for MMT-205, a bispecific antibody that activates Tie2 and inhibits VEGF simultaneously — targeting the largest unmet gaps in nAMD and DME treatment.
Get daily updates on the technologies and investment opportunities shaping the next decade — from AI infrastructure and autonomous systems to biotech, space, and defence. Curated analysis, no noise.
